Phase II Study of Amrubicin Monotherapy in Elderly or Poor-Risk Patients with Extensive Disease of Small Cell Lung Cancer

被引:0
|
作者
Igawa, S. [1 ]
Fukui, T. [1 ]
Shirasawa, M. [1 ]
Ozawa, T. [1 ]
Sone, H. [1 ]
Kusuhara, S. [1 ]
Nishinarita, N. [1 ]
Hiyoshi, Y. [1 ]
Kubota, M. [1 ]
Mitsufuji, H. [2 ]
Sasaki, J. [3 ]
Katagiri, M. [4 ]
Naoki, K. [1 ]
机构
[1] Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan
[2] Kitasato Univ, Sch Nursing, Sagamihara, Kanagawa, Japan
[3] Kitasato Univ, Sch Med, Res & Dev Ctr New Med Frontiers, Sagamihara, Kanagawa, Japan
[4] Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa, Japan
关键词
Small Cell Lung Cancer; Elderly patients; Performance status; Amrubicin;
D O I
10.1016/j.jtho.2018.08.837
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.12-02
引用
收藏
页码:S573 / S573
页数:1
相关论文
共 50 条
  • [21] A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer
    Shibayama, Takuo
    Hotta, Katsuyuki
    Takigawa, Nagio
    Tada, Atsuhiko
    Ueoka, Hiroshi
    Harita, Shingo
    Kiura, Katsuyuki
    Tabata, Masahiro
    Segawa, Yoshihiko
    Nogami, Naoyuki
    Kuyama, Shoichi
    Shinkai, Tetsu
    Tanimoto, Mitsune
    LUNG CANCER, 2006, 53 (02) : 189 - 195
  • [22] Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer
    Hirose, Takashi
    Nakashima, Masanao
    Shirai, Takao
    Kusumoto, Sojiro
    Sugiyama, Tomohide
    Yamaoka, Toshimitsu
    Okuda, Kentaro
    Ohnishi, Tsukasa
    Ohmori, Tohru
    Adachi, Mitsuru
    LUNG CANCER, 2011, 73 (03) : 345 - 350
  • [23] A PHASE II STUDY OF AMRUBICIN AND TOPOTECAN COMBINATION THERAPY IN PATIENTS WITH RELAPSED OR EXTENSIVE-DISEASE SMALL-CELL LUNG CANCER: OKAYAMA LUNG CANCER STUDY GROUP TRIAL 0401
    Nogami, Naoyuki
    Kozuki, Toshiyuki
    Shinkai, Tetsu
    Katou, Yuka
    Hotta, Katsuyki
    Takigawa, Nagio
    Tabata, Masahiro
    Kiura, Katsuyuki
    Tanimoto, Mitsune
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S643 - S644
  • [24] Amrubicin Monotherapy for Elderly Patients with Previously Treated Lung Cancer
    Nakao, Makoto
    Oguri, Tetsuya
    Suzuki, Takeshi
    Kunii, Eiji
    Tomita, Yuki
    Iwashima, Yasuhito
    Miyazaki, Mikinori
    Maeno, Ken
    Sato, Shigeki
    Ueda, Ryuzo
    INTERNAL MEDICINE, 2010, 49 (17) : 1857 - 1862
  • [25] A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401
    Nogami, Naoyuki
    Hotta, Katsuyuki
    Kuyama, Shoichi
    Kiura, Katsuyuki
    Takigawa, Nagio
    Chikamori, Kenichi
    Shibayama, Takuo
    Kishino, Daizo
    Hosokawa, Shinobu
    Tamaoki, Akihiko
    Harita, Shingo
    Tabata, Masahiro
    Ueoka, Hiroshi
    Shinkai, Tetsu
    Tanimoto, Mitsune
    LUNG CANCER, 2011, 74 (01) : 80 - 84
  • [26] A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer
    Yeo, Chang Dong
    Lee, Sang Haak
    Kim, Ju Sang
    Kim, Seung Joon
    Kim, Seok Chan
    Kim, Young Kyoon
    Kang, Hyeon Hui
    Yoon, Hyung Kyu
    Song, Jeong Sup
    Moon, Hwa Sik
    Kim, Jin Woo
    Kim, Kwan Hyoung
    Shim, Byoung Yong
    Kim, Chi Hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 809 - 814
  • [27] Gemcitabine monotherapy in elderly patients with advanced iron-small cell lung cancer - A multicenter phase II study
    Ricci, S
    Antonuzzo, A
    Galli, L
    Tibaldi, C
    Bertuccelli, M
    Pegna, AL
    Petruzzelli, S
    Algeri, R
    Bonifazi, V
    Fioretto, ML
    Orlandini, C
    Conte, PF
    LUNG CANCER, 2000, 27 (02) : 75 - 80
  • [28] Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer
    Ohe, Y
    Negoro, S
    Matsui, K
    Nakagawa, K
    Sugiura, T
    Takada, Y
    Nishiwaki, Y
    Yokota, S
    Kawahara, M
    Saijo, N
    Fukuoka, M
    Ariyoshi, Y
    ANNALS OF ONCOLOGY, 2005, 16 (03) : 430 - 436
  • [29] A phase II study of biweekly irinotecan and cisplatin for patients with extensive stage disease small cell lung cancer
    Bae, Sung Hwa
    Ryoo, Hun Mo
    Do, Young Rok
    Song, Hong Suk
    Kwon, Ki Young
    Kim, Min Kyoung
    Lee, Kyung Hee
    Hyun, Myung Soo
    Lee, Won Sik
    Hur, In Kyong
    Baek, Jin Ho
    Park, Keon Uk
    LUNG CANCER, 2008, 59 (01) : 76 - 80
  • [30] Clinical impact of amrubicin monotherapy in patients with relapsed small cell lung cancer: a multicenter retrospective study
    Uda, Sayaka
    Yamada, Tadaaki
    Yoshimura, Akihiro
    Goto, Yasuhiro
    Yoshimine, Kohei
    Nakamura, Yoichi
    Shiotsu, Shinsuke
    Yokoi, Takashi
    Tamiya, Nobuyo
    Kimura, Hideharu
    Chihara, Yusuke
    Umeda, Yukihiro
    Izumi, Miiru
    Takeda, Takayuki
    Yamada, Takahiro
    Hibino, Makoto
    Hiranuma, Osamu
    Ito, Kazuhiro
    Okada, Asuka
    Osugi, Shuji
    Takemura, Yoshizumi
    Ishii, Hiroshi
    Chibana, Kenji
    Hasegawa, Isao
    Morimoto, Yoshie
    Iwasaku, Masahiro
    Tokuda, Shinsaku
    Takayama, Koichi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, : 1847 - 1857